En
Da
Fr
De
Sv
Deal History
About us
The Company
Team
Offices
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
En
Da
Fr
De
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
12 Sep 2024
Research update Biosergen: First patient treated in phase Ib study a success
Equity Research
Biosergen
11 Sep 2024
Carlsquare weekly market letter: How to deal with a stormy market
Equity Research
Carlsquare
09 Sep 2024
Equity Research Svenska Aerogel, Q2 2024: Low revenues, but important orders in place
Equity Research
Svenska Aerogel
05 Sep 2024
Equity research Zinzino: Making a late summer splash
Equity Research
Zinzino
04 Sep 2024
Carlsquare weekly market letter: Time for a new bump in the road?
Equity Research
Carlsquare
03 Sep 2024
Equity Research Enrad Q2 2024: Enrad should invest in growing markets
Equity Research
Enrad
02 Sep 2024
Equity research Zinzino: Robust profit growth despite lower gross margin in Q2 2024
Equity Research
Zinzino
30 Aug 2024
Equity research Enrad, Q2 2024: Very strong quarter
Equity Research
Enrad
30 Aug 2024
Equity research Zinzino: Profit growth despite pressure on gross margin in Q2 2024
Equity Research
Zinzino
29 Aug 2024
Equity Research Svenska Aerogel, Q2 2024: Net revenues below expectations, but better profitability
Equity Research
Svenska Aerogel
29 Aug 2024
Equity research Viva Wine Group: Profitability uptick ahead of expectations
Equity Research
Viva Wine Group
29 Aug 2024
Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow
Equity Research
Nosa Plugs
28 Aug 2024
Equity research Viva Wine Group: Return to strong EBITA growth in Q2 2024
Equity Research
Viva Wine Group
28 Aug 2024
Carlsquare weekly market letter: Does the Fed know something we don't?
Equity Research
Carlsquare
23 Aug 2024
Equity Research Nosa Plugs: First impression Q2, 2024
Equity Research
Nosa Plugs
22 Aug 2024
Equity Research GIAB, Q2 2024: Getting to break even with a better plan
Equity Research
GIAB
22 Aug 2024
Equity research, Teneo AI: Strong growth outlook remains after a solid Q2
Equity Research
Teneo AI
21 Aug 2024
Equity research Teneo AI: A solid Q2 report with an impressive API call growth
Equity Research
Teneo AI
21 Aug 2024
Equity Research Ecoclime, Q2 2024: Increased focus on Evertherm sales
Equity Research
Ecoclime
21 Aug 2024
Carlsquare weekly market letter: Two-sided market with internal rotations, but trend still positive
Equity Research
Carlsquare
1
2
3
…
52
